After stratifying glioma samples according to WHO grade and 1p/19q codeletion status, we found lower expression levels of CEBPA, Galectin-9, and TIM-3 proteins in whole grade glioma samples with 1p/19q codeletion compared with those in samples with retained 1p/19q or normal tissues (Figures 6A, B). The gene discussed is HAVCR2; the disease is central nervous system cancer.